Latest News
From the Journals
CGM completes picture of A1c in type 2 diabetes
“This may help empower people with diabetes to better manage their condition, giving them practical insights into the factors driving daily...
From the Journals
Endovascular approach best for below-knee limb-threatening ischemia?
“Our findings suggest that a best endovascular treatment first revascularization strategy is associated with a better amputation-free survival.”...
Latest News
Medical students gain momentum in effort to ban legacy admissions
Opponents of legacy admissions say it penalizes students from racial minorities and lower socioeconomic backgrounds, hampering a fair and...
Latest News
Five ways docs may qualify for discounts on medical malpractice premiums
Most states cap discounts at 25%, but some go as high as 70%.
Latest News
Bundled strategy increased preteen lipid screening
An intervention included in-office testing, provider education, and EMR updates.
Conference Coverage
Surprisingly more nonsustained VT shown in HCM using extended ECG monitoring
Nonsustained ventricular tachycardia, an important arrhythmia used every day in clinical practice to make decisions, is “much, much more prevalent...
News from the FDA/CDC
FDA expands use of dapagliflozin to broader range of HF
The sodium-glucose cotransporter 2 inhibitor was previously approved in the United States for adults with heart failure with reduced ejection...
From the Journals
AHA flags differing CVD risk in Asian American subgroups
Together, T2D and ASCVD are the leading causes of illness and death among Asian American adults, but there is significant variability in...
Conference Coverage
New AACE type 2 diabetes algorithm individualizes care
Splitting the glucose-lowering algorithms into “complications-centric” and “glucose-centric” graphics is new.
From the Journals
A call to revamp revascularization trial endpoints
Coronary revascularization trials should focus more on quality of life than traditional composite outcomes, two trial investigators say.
Commentary
Why the approval of MiniMed 780G is a ‘quantum leap’ forward
The FDA approval of the MiniMed 780G artificial pancreas promises better glucose control in patients with type 1 diabetes, and Dr. Ann Peters is “...